Health @ TuxfordThe NHS has announced that a new weight-loss injection called Mounjaro (tirzepatide) will soon be available to help people with obesity. This news has created a lot of interest, and we’ve been getting many questions about it.
What is Mounjaro?
Mounjaro is a new injection designed to help with weight loss. It works by making you feel full, so you eat less. In trials, people using Mounjaro lost up to 20% of their body weight.
The NHS plans to make this injection available from March 2025 for people who:
- Have a Body Mass Index (BMI) over 35.
- Have at least one obesity-related health problem, like Type 2 diabetes, high blood pressure, or heart disease.
However, at first, Mounjaro will only be available to patients in specialist weight-management services. The wider rollout, which may include GP practices, is expected to start later in the year.
When Will It Be Available?
The NHS has a long-term plan to make Mounjaro widely available. However, this will take time – possibly up to 12 years – to ensure services can manage the demand.
From March 2025, the injection will be offered to those with the highest medical need. Over the next three years, about 220,000 people are expected to benefit from it.
For now, GP practices like ours are waiting for further guidance on how and when this injection will become available for more patients.
Further information regarding availability of Mounjaro to NHS patients in Nottinghamshire is available here.
What we can offer right now…
NHS Health Checks: These include weight management advice and checks for other health conditions.
Diet and Exercise Advice: Our team can guide you on making lifestyle changes to help manage your weight.
Support Services: We can connect you with other NHS programs that focus on healthy weight management.
Important
At the time of writing, Mounjaro is only available through specific NHS specialist services.
Read More
For more information about Mounjaro and its rollout, you can read the full BBC article here.